Mitochondria are targets of cold ischemia-reperfusion (IR), the major cause of cell damage during static cold preservation of liver allografts. The bioactivity of methane (CH4) has recently been recognized in various hypoxic and IR conditions as having influence on many aspects of mitochondrial biology. We therefore hypothesized that cold storage of liver grafts in CH4-enriched preservation solution can provide an increased defence against organ dysfunction in a preclinical rat model of liver transplantation. Livers were preserved for 24 h in cold histidine–tryptophan–ketoglutarate (HTK) or CH4-enriched HTK solution (HTK-CH4) (n = 24 each); then, viability parameters were monitored for 60 min during normothermic isolated reperfusion and perfusate and liver tissue were collected. The oxidative phosphorylation capacity and extramitochondrial Ca2+ movement were measured by high resolution respirometry. Oxygen and glucose consumption increased significantly while hepatocellular damage was decreased in the HTK-CH4 grafts compared to the HTK group. Mitochondrial oxidative phosphorylation capacity was more preserved (128.8 ± 31.5 pmol/s/mL vs 201.3 ± 54.8 pmol/s/mL) and a significantly higher Ca2+ flux was detected in HTK-CH4 storage (2.9 ± 0.1 mV/s) compared to HTK (2.3 ± 0.09 mV/s). These results demonstrate the direct effect of CH4 on hepatic mitochondrial function and extramitochondrial Ca2+ fluxes, which may have contributed to improved graft functions and a preserved histomorphology after cold IR.
Despite their clinical effectiveness, a growing body of evidence has shown that many classes of antibiotics lead to mitochondrial dysfunction. Ceftriaxone and Rifaximin are first choice perioperative antibiotics in gastrointestinal surgery targeting fundamental processes of intestinal bacteria; however, may also have negative consequences for the host cells. In this study, we investigated their direct effect on mitochondrial functions in vitro, together with their impact on ileum, colon and liver tissue. Additionally, their impact on the gastrointestinal microbiome was studied in vivo, in a rat model. Rifaximin significantly impaired the oxidative phosphorylation capacity (OxPhos) and leak respiration in the ileal mucosa, in line with increased oxidative tissue damage and histological changes following treatment. Ceftriaxone prophylaxis led to similar changes in the colon mucosa. The composition and diversity of bacterial communities differed extensively in response to antibiotic pre-treatment. However, the relative abundances of the toxin producing species were not increased. We have confirmed the harmful effects of prophylactic doses of Rifaximin and Ceftriaxone on the intestinal mucosa and that these effects were related to the mitochondrial dysfunction. These experiments raise awareness of mitochondrial side effects of these antibiotics that may be of clinical importance when evaluating their adverse effects on bowel mucosa.
The majority of potentially preventable mortality in trauma patients is related to bleeding; therefore, early recognition and effective treatment of hemorrhagic shock impose a cardinal challenge for trauma teams worldwide. The reduction in mesenteric perfusion (MP) is among the first compensatory responses to blood loss; however, there is no adequate tool for splanchnic hemodynamic monitoring in emergency patient care. In this narrative review, (i) methods based on flowmetry, CT imaging, video microscopy (VM), measurement of laboratory markers, spectroscopy, and tissue capnometry were critically analyzed with respect to their accessibility, and applicability, sensitivity, and specificity. (ii) Then, we demonstrated that derangement of MP is a promising diagnostic indicator of blood loss. (iii) Finally, we discussed a new diagnostic method for the evaluation of hemorrhage based on exhaled methane (CH4) measurement. Conclusions: Monitoring the MP is a feasible option for the evaluation of blood loss. There are a wide range of experimentally used methodologies; however, due to their practical limitations, only a fraction of them could be integrated into routine emergency trauma care. According to our comprehensive review, breath analysis, including exhaled CH4 measurement, would provide the possibility for continuous, non-invasive monitoring of blood loss.
A nagy vérvesztéssel járó műtétek esetén a perfúziós elégtelenség korai felismerése elengedhetetlen, mivel a hipovolemiás sokk a vérzés következtében az egyik leggyakoribb, de megelőzhető halálok. A jelenleg alkalmazott hemodinamikai paraméterek, mint a vérnyomás és a szívfrekvencia, korlátozott prediktív értékkel bírnak. A kilélegzett metán (CH4) koncentrációjának mérése a mesenterialis perfúzió monitorozásának új lehetősége, mivel a vérvesztés elsődleges reakciója az arteria mesenterica superior (SMA) véráramlásának csökkenése. Az SMA által ellátott bélszegmens flórája pedig a kilélegzett metán elsődleges forrása. Célunk a kilélegzett CH4 változásának vizsgálata nagyízületi endoprotézis beültetésen átesett betegeknél. 2024.09.01. és 2024.10.31. között a Szegedi Tudományegyetem Traumatológiai és Ortopédiai Klinikáján prospektív kutatást végeztünk, amely során nagyízületi endoprotézis beültetett betegek kilélegzett CH4 koncentrációt vizsgáltuk pre- és posztoperatívan. A méréseket fotoakusztikus spektroszkóp (PAS) készülékkel végeztük. Ezen kívül nyomon követtük a műtéti vérveszteséget, az adminisztrált folyadékokat és a vitális paramétereket az aneszteziológiai dokumentáció alapján. 25 beteget vizsgáltunk meg (56% férfi, 44% nő, átlagéletkor: 66.12 ± 9.72év). A betegek 32%-a volt CH4-termelő. Az átlagos vérvesztés 262 ± 159.61 ml volt, a beadott krisztalloid mennyisége 747,83 ± 307,29 ml, a kolloid mennyisége pedig 521,42 ± 80,18 ml. A kilélegzett CH4 változása és a vérvesztés mértéke közötti összefüggés közepes pozitív volt (r = 0,57), de nem bizonyult statisztikailag szignifikánsnak (p = 0,1386). Eredményeinket a műtéti vérvesztés alacsony szintje és a kis elemszám korlátozza. Amennyiben nagyobb elemszámú vizsgálatok megerősítik ezeket az eredményeket, a CH4 valós idejű monitorozása hasznos lehet a vérvesztés korai felismerésében, és javíthatja a sürgősségi és műtéti ellátás minőségét.